Does Prophylactic Oral Zinc Reduce the Risk of Contracting COVID-19?
Sean D Adrean, Kenneth Schmitt, Caleb Ng, Ash Pirouz, Hema L Ramkumar, Scott Grant
Cureus, doi:10.7759/cureus.30881
In this study, we aimed to investigate whether zinc provided in Age-Related Eye Disease Study 2 (AREDS2) vitamins is associated with a decreased risk of contracting coronavirus disease 2019 .
Materials and methods We conducted a retrospective observational cohort study involving patients at a retina-only practice who were provided a questionnaire at each visit to assess whether they were symptomatic of or had contracted COVID-19. Those who answered yes to testing positive for COVID-19 were retrospectively analyzed and categorized based on their AREDS2 vitamin use, and a Pearson's chi-squared test was performed. Demographic data and past ocular history were also analyzed.
Results A total of 8,426 unique patients, including 2,111 with a diagnosis of age-related macular degeneration (AMD), were seen from April 1, 2020, to April 9, 2021. A total of 110 patients (1.3%) reported contracting COVID-19 and had positive COVID-19 tests. The average age of those who had contracted COVID-19 in this study was 68.3 years; 51.8% were male, 30.1% had AMD, 28.2% had diabetic retinopathy, 24.5% had surgical retinal disease, 11.8% had retinal vascular disease, and 4.5% had other disease states. Of the COVID-19positive patients, 27.3% (30/110) took AREDS2 vitamins, while 72.7% (80/110) patients did not. A chisquared analysis was performed, which was not statistically significant (p=0.667).
Conclusions Oral zinc supplementation, in the form of AREDS2 vitamins, is not associated with a protective effect against contracting COVID-19.
Conclusions Oral zinc supplementation has been widely purported to reduce symptomatic viral days. It has also been recommended to be used as a prophylaxis for viral infections. It has been speculated that it may help reduce the chance of contracting COVID-19. Zinc is readily available over the counter and is used in the AREDS supplements for macular degeneration. Elderly patients are at increased risk of complications from COVID-19, and hence if zinc supplementation could reduce the chance of contracting COVID-19, that would be highly beneficial. However, based on our findings, oral zinc supplementation in the form of AREDS2 vitamins is not associated with a protective effect against contracting COVID-19.
Appendices
References
Voysey, Clemens, Madhi, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine
{ 'indexed': { 'date-parts': [[2022, 10, 31]],
'date-time': '2022-10-31T04:40:55Z',
'timestamp': 1667191255207},
'reference-count': 29,
'publisher': 'Cureus, Inc.',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2022, 10, 30]]},
'DOI': '10.7759/cureus.30881',
'type': 'journal-article',
'created': { 'date-parts': [[2022, 10, 30]],
'date-time': '2022-10-30T20:33:06Z',
'timestamp': 1667161986000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Does Prophylactic Oral Zinc Reduce the Risk of Contracting COVID-19?',
'prefix': '10.7759',
'author': [ {'given': 'Sean D', 'family': 'Adrean', 'sequence': 'first', 'affiliation': []},
{'given': 'Kenneth', 'family': 'Schmitt', 'sequence': 'additional', 'affiliation': []},
{'given': 'Caleb', 'family': 'Ng', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ash', 'family': 'Pirouz', 'sequence': 'additional', 'affiliation': []},
{'given': 'Hema L', 'family': 'Ramkumar', 'sequence': 'additional', 'affiliation': []},
{'given': 'Scott', 'family': 'Grant', 'sequence': 'additional', 'affiliation': []}],
'member': '4492',
'reference': [ { 'key': 'ref1',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/s41579-020-00468-6',
'article-title': 'Coronavirus biology and replication: implications for SARS-CoV-2',
'volume': '19',
'author': "V'kovski P",
'year': '2021',
'unstructured': "V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus "
'biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. '
'2021, 19:155-70. 10.1038/s41579-020-00468-6',
'journal-title': 'Nat Rev Microbiol'},
{ 'key': 'ref2',
'doi-asserted-by': 'publisher',
'DOI': '10.14218/JCTH.2020.00018',
'article-title': 'COVID-19 and liver dysfunction: current insights and emergent '
'therapeutic strategies',
'volume': '8',
'author': 'Feng G',
'year': '2020',
'unstructured': 'Feng G, Zheng KI, Yan QQ, et al.. COVID-19 and liver dysfunction: '
'current insights and emergent therapeutic strategies. J Clin Transl '
'Hepatol. 2020, 8:18-24. 10.14218/JCTH.2020.00018',
'journal-title': 'J Clin Transl Hepatol'},
{ 'key': 'ref3',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa200776',
'article-title': 'Remdesivir for the treatment of COVID-19 - preliminary report',
'volume': '383',
'author': 'McMahon JH',
'year': '2020',
'unstructured': 'McMahon JH, Udy A, Peleg AY. Remdesivir for the treatment of COVID-19 - '
'preliminary report. N Engl J Med. 2020, 383:992-3. 10.1056/NEJMoa200776',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref4',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2021436',
'article-title': 'Dexamethasone in hospitalized patients with Covid-19',
'volume': '384',
'author': 'Horby P',
'year': '2021',
'unstructured': 'Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized '
'patients with Covid-19. N Engl J Med. 2021, 384:693-704. '
'10.1056/NEJMoa2021436',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref5',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMp2032369',
'article-title': 'FDA approval of remdesivir - a step in the right direction',
'volume': '383',
'author': 'Rubin D',
'year': '2020',
'unstructured': 'Rubin D, Chan-Tack K, Farley J, Sherwat A. FDA approval of remdesivir - '
'a step in the right direction. N Engl J Med. 2020, 383:2598-600. '
'10.1056/NEJMp2032369',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref6',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2101544',
'article-title': 'Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19',
'volume': '384',
'author': 'Sadoff J',
'year': '2021',
'unstructured': 'Sadoff J, Gray G, Vandebosch A, et al.. Safety and efficacy of '
'single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021, '
'384:2187-201. 10.1056/NEJMoa2101544',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref7',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)32661-1',
'article-title': 'Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against '
'SARS-CoV-2: an interim analysis of four randomised controlled trials in '
'Brazil, South Africa, and the UK',
'volume': '397',
'author': 'Voysey M',
'year': '2021',
'unstructured': 'Voysey M, Clemens SA, Madhi SA, et al.. Safety and efficacy of the '
'ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim '
'analysis of four randomised controlled trials in Brazil, South Africa, '
'and the UK. Lancet. 2021, 397:99-111. 10.1016/S0140-6736(20)32661-1',
'journal-title': 'Lancet'},
{ 'key': 'ref8',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2108891',
'article-title': 'Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) '
'variant',
'volume': '385',
'author': 'Lopez Bernal J',
'year': '2021',
'unstructured': 'Lopez Bernal J, Andrews N, Gower C, et al.. Effectiveness of Covid-19 '
'vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021, '
'385:585-94. 10.1056/NEJMoa2108891',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref9',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s12011-020-02437-9',
'article-title': 'Zinc and COVID-19: basis of current clinical trials',
'volume': '199',
'author': 'Pal A',
'year': '2021',
'unstructured': 'Pal A, Squitti R, Picozza M, et al.. Zinc and COVID-19: basis of current '
'clinical trials. Biol Trace Elem Res. 2021, 199:2882-92. '
'10.1007/s12011-020-02437-9',
'journal-title': 'Biol Trace Elem Res'},
{ 'key': 'ref10',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.abb.2016.03.022',
'article-title': 'Zinc and immunity: an essential interrelation',
'volume': '611',
'author': 'Maares M',
'year': '2016',
'unstructured': 'Maares M, Haase H. Zinc and immunity: an essential interrelation. Arch '
'Biochem Biophys. 2016, 611:58-65. 10.1016/j.abb.2016.03.022',
'journal-title': 'Arch Biochem Biophys'},
{ 'key': 'ref11',
'doi-asserted-by': 'publisher',
'DOI': '10.3945/an.112.003038',
'article-title': 'Zinc biochemistry: from a single zinc enzyme to a key element of life',
'volume': '4',
'author': 'Maret W',
'year': '2013',
'unstructured': 'Maret W. Zinc biochemistry: from a single zinc enzyme to a key element '
'of life. Adv Nutr. 2013, 4:82-91. 10.3945/an.112.003038',
'journal-title': 'Adv Nutr'},
{ 'key': 'ref12',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s00775-011-0797-4',
'article-title': 'Zinc homeostasis and signaling in health and diseases: zinc signaling',
'volume': '16',
'author': 'Fukada T',
'year': '2011',
'unstructured': 'Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T. Zinc homeostasis '
'and signaling in health and diseases: zinc signaling. J Biol Inorg Chem. '
'2011, 16:1123-34. 10.1007/s00775-011-0797-4',
'journal-title': 'J Biol Inorg Chem'},
{ 'key': 'ref13',
'doi-asserted-by': 'publisher',
'DOI': '10.1177/0148607115572193',
'article-title': 'Safety and dose escalation study of intravenous zinc supplementation in '
'pediatric critical illness',
'volume': '40',
'author': 'Cvijanovich NZ',
'year': '2016',
'unstructured': 'Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Vinks AA, Wong HR. '
'Safety and dose escalation study of intravenous zinc supplementation in '
'pediatric critical illness. JPEN J Parenter Enteral Nutr. 2016, '
'40:860-8. 10.1177/0148607115572193',
'journal-title': 'JPEN J Parenter Enteral Nutr'},
{ 'key': 'ref14',
'doi-asserted-by': 'publisher',
'DOI': '10.1331/1544-3191.44.5.594.hulisz',
'article-title': 'Efficacy of zinc against common cold viruses: an overview',
'volume': '44',
'author': 'Hulisz D',
'year': '2004',
'unstructured': 'Hulisz D. Efficacy of zinc against common cold viruses: an overview. J '
'Am Pharm Assoc (2003). 2004, 44:594-603. '
'10.1331/1544-3191.44.5.594.hulisz',
'journal-title': 'J Am Pharm Assoc (2003)'},
{ 'key': 'ref15',
'doi-asserted-by': 'publisher',
'DOI': '10.1128/AAC.48.3.783-790.2004',
'article-title': 'Effect of zinc salts on respiratory syncytial virus replication',
'volume': '48',
'author': 'Suara RO',
'year': '2004',
'unstructured': 'Suara RO, Crowe JE Jr. Effect of zinc salts on respiratory syncytial '
'virus replication. Antimicrob Agents Chemother. 2004, 48:783-90. '
'10.1128/AAC.48.3.783-790.2004',
'journal-title': 'Antimicrob Agents Chemother'},
{ 'key': 'ref16',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.ppat.1001176',
'article-title': 'Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in '
'vitro and zinc ionophores block the replication of these viruses in '
'cell culture',
'volume': '6',
'author': 'te Velthuis AJ',
'year': '2010',
'unstructured': 'te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van '
'Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase '
'activity in vitro and zinc ionophores block the replication of these '
'viruses in cell culture. PLoS Pathog. 2010, 6:e1001176. '
'10.1371/journal.ppat.1001176',
'journal-title': 'PLoS Pathog'},
{ 'key': 'ref17',
'doi-asserted-by': 'publisher',
'DOI': '10.1093/advances/nmz013',
'article-title': 'The role of zinc in antiviral immunity',
'volume': '10',
'author': 'Read SA',
'year': '2019',
'unstructured': 'Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in '
'antiviral immunity. Adv Nutr. 2019, 10:696-710. 10.1093/advances/nmz013',
'journal-title': 'Adv Nutr'},
{ 'key': 'ref18',
'doi-asserted-by': 'publisher',
'DOI': '10.3945/an.116.013177',
'article-title': 'The age-related eye disease 2 study: micronutrients in the treatment of '
'macular degeneration',
'volume': '8',
'author': 'Gorusupudi A',
'year': '2017',
'unstructured': 'Gorusupudi A, Nelson K, Bernstein PS. The age-related eye disease 2 '
'study: micronutrients in the treatment of macular degeneration. Adv '
'Nutr. 2017, 8:40-53. 10.3945/an.116.013177',
'journal-title': 'Adv Nutr'},
{ 'key': 'ref19',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.ajo.2020.04.028',
'article-title': 'Investigate oral zinc as a prophylactic treatment for those at risk for '
'COVID-19',
'volume': '216',
'author': 'McPherson SW',
'year': '2020',
'unstructured': 'McPherson SW, Keunen JE, Bird AC, Chew EY, van Kuijk FJ. Investigate '
'oral zinc as a prophylactic treatment for those at risk for COVID-19. Am '
'J Ophthalmol. 2020, 216:A5-6. 10.1016/j.ajo.2020.04.028',
'journal-title': 'Am J Ophthalmol'},
{ 'key': 'ref20',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/archopht.119.10.1417',
'article-title': 'A randomized, placebo-controlled, clinical trial of high-dose '
'supplementation with vitamins C and E, beta carotene, and zinc for '
'age-related macular degeneration and vision loss: AREDS report no. 8',
'volume': '119',
'author': 'Age-Related Eye Disease Study Research Group',
'year': '2001',
'unstructured': 'Age-Related Eye Disease Study Research Group. A randomized, '
'placebo-controlled, clinical trial of high-dose supplementation with '
'vitamins C and E, beta carotene, and zinc for age-related macular '
'degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001, '
'119:1417-36. 10.1001/archopht.119.10.1417',
'journal-title': 'Arch Ophthalmol'},
{ 'key': 'ref21',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/nature02145',
'article-title': 'Angiotensin-converting enzyme 2 is a functional receptor for the SARS '
'coronavirus',
'volume': '426',
'author': 'Li W',
'year': '2003',
'unstructured': 'Li W, Moore MJ, Vasilieva N, et al.. Angiotensin-converting enzyme 2 is '
'a functional receptor for the SARS coronavirus. Nature. 2003, 426:450-4. '
'10.1038/nature02145',
'journal-title': 'Nature'},
{ 'key': 'ref22',
'doi-asserted-by': 'publisher',
'DOI': '10.1136/bmjopen-2020-047474',
'article-title': 'Zinc for the prevention or treatment of acute viral respiratory tract '
'infections in adults: a rapid systematic review and meta-analysis of '
'randomised controlled trials',
'volume': '11',
'author': 'Hunter J',
'year': '2021',
'unstructured': 'Hunter J, Arentz S, Goldenberg J, et al.. Zinc for the prevention or '
'treatment of acute viral respiratory tract infections in adults: a rapid '
'systematic review and meta-analysis of randomised controlled trials. BMJ '
'Open. 2021, 11:e047474. 10.1136/bmjopen-2020-047474',
'journal-title': 'BMJ Open'},
{ 'key': 'ref23',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.chest.2020.06.082',
'article-title': 'The minimal effect of zinc on the survival of hospitalized patients '
'with COVID-19: an observational study',
'volume': '159',
'author': 'Yao JS',
'year': '2021',
'unstructured': 'Yao JS, Paguio JA, Dee EC, et al.. The minimal effect of zinc on the '
'survival of hospitalized patients with COVID-19: an observational study. '
'Chest. 2021, 159:108-11. 10.1016/j.chest.2020.06.082',
'journal-title': 'Chest'},
{ 'key': 'ref24',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamanetworkopen.2021.0369',
'article-title': 'Effect of high-dose zinc and ascorbic acid supplementation vs usual '
'care on symptom length and reduction among ambulatory patients with '
'SARS-CoV-2 infection: the COVID A to Z randomized clinical trial',
'volume': '4',
'author': 'Thomas S',
'year': '2021',
'unstructured': 'Thomas S, Patel D, Bittel B, et al.. Effect of high-dose zinc and '
'ascorbic acid supplementation vs usual care on symptom length and '
'reduction among ambulatory patients with SARS-CoV-2 infection: the COVID '
'A to Z randomized clinical trial. JAMA Netw Open. 2021, 4:e210369. '
'10.1001/jamanetworkopen.2021.0369',
'journal-title': 'JAMA Netw Open'},
{ 'key': 'ref25',
'doi-asserted-by': 'publisher',
'DOI': '10.1111/bcp.14826',
'article-title': 'Zinc supplementation as an adjunct therapy for COVID-19: challenges and '
'opportunities',
'volume': '87',
'author': 'Chinni V',
'year': '2021',
'unstructured': 'Chinni V, El-Khoury J, Perera M, et al.. Zinc supplementation as an '
'adjunct therapy for COVID-19: challenges and opportunities. Br J Clin '
'Pharmacol. 2021, 87:3737-46. 10.1111/bcp.14826',
'journal-title': 'Br J Clin Pharmacol'},
{ 'key': 'ref26',
'doi-asserted-by': 'publisher',
'DOI': '10.3945/ajcn.2010.28674I',
'article-title': 'Zinc bioavailability and homeostasis',
'volume': '91',
'author': 'Hambidge KM',
'year': '2010',
'unstructured': 'Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF. Zinc '
'bioavailability and homeostasis. Am J Clin Nutr. 2010, 91:1478S-83S. '
'10.3945/ajcn.2010.28674I',
'journal-title': 'Am J Clin Nutr'},
{ 'key': 'ref27',
'doi-asserted-by': 'publisher',
'DOI': '10.3390/nu12030762',
'article-title': 'A guide to human zinc absorption: general overview and recent advances '
'of in vitro intestinal models',
'volume': '12',
'author': 'Maares M',
'year': '2020',
'unstructured': 'Maares M, Haase H. A guide to human zinc absorption: general overview '
'and recent advances of in vitro intestinal models. Nutrients. 2020, '
'12:762. 10.3390/nu12030762',
'journal-title': 'Nutrients'},
{ 'key': 'ref28',
'doi-asserted-by': 'publisher',
'DOI': '10.1080/00325481.2020.1786964',
'article-title': 'COVID-19 and comorbidities: a systematic review and meta-analysis',
'volume': '132',
'author': 'Gold MS',
'year': '2020',
'unstructured': 'Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. '
'COVID-19 and comorbidities: a systematic review and meta-analysis. '
'Postgrad Med. 2020, 132:749-55. 10.1080/00325481.2020.1786964',
'journal-title': 'Postgrad Med'},
{ 'key': 'ref29',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s15010-020-01509-1',
'article-title': 'Risk factors for Covid-19 severity and fatality: a structured '
'literature review',
'volume': '49',
'author': 'Wolff D',
'year': '2021',
'unstructured': 'Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 '
'severity and fatality: a structured literature review. Infection. 2021, '
'49:15-28. 10.1007/s15010-020-01509-1',
'journal-title': 'Infection'}],
'container-title': 'Cureus',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.cureus.com/articles/119536-does-prophylactic-oral-zinc-reduce-the-risk-of-contracting-covid-19',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 10, 30]],
'date-time': '2022-10-30T20:33:09Z',
'timestamp': 1667161989000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/119536-does-prophylactic-oral-zinc-reduce-the-risk-of-contracting-covid-19'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 10, 30]]},
'references-count': 29,
'URL': 'http://dx.doi.org/10.7759/cureus.30881',
'relation': {},
'ISSN': ['2168-8184'],
'subject': ['Aerospace Engineering'],
'published': {'date-parts': [[2022, 10, 30]]}}